shouldiuse.io

VERDICT

Should I use ReadCube?

Need literature management for your research driven company? ReadCube helps your company discover, organize, read, annotate, share and cite. - papersapp.com

Depends. Buy it if research literature is core to your company's output — Moderna and Boehringer Ingelheim case studies back that up. Skip it if you just need to store a few papers; free Zotero or Mendeley handles that fine.

Confidence

Medium. Based on 20+ public sources; pricing partly dated (2022 listing), and several review snippets were truncated.

Ratings

  • Value for money
  • Ease of use
  • Feature depth
  • Support qualityNo support evidence found
  • Security posture

Pricing

From $3/mo

Individual

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed
GroupNot publicly listed

Best for

  • Research-driven companies and R&D teams
  • Pharma, biotech and medical affairs groups
  • Labs sharing and annotating papers together
  • Individual scientists managing large PDF libraries

Not for

  • Casual readers with a handful of PDFs
  • Small teams without a real literature workflow — overkill
  • Anyone wanting a free tool; Zotero and Mendeley do the basics
  • Buyers needing pricing clarity — public tiers are vague

Gotchas - check before you buy

medium

The $3/mo entry price is a 2022 listing; current pricing may differ — verify before committing

medium

Group plan caps at 10 users per group

medium

Papers–ReadCube merger left users publicly questioning the product's roadmap

Pros and cons

Pros

  • Covers the full loop: discover, organize, read, annotate, share, cite
  • AI assistant helps summarize papers for faster reading
  • Literature monitoring surfaces new research automatically
  • Real enterprise case studies: Moderna, Boehringer Ingelheim, Medscape, Roivant
  • Published security statement; GDPR compliance since 2018

Cons

  • Users still ask what happened to the Papers app post-merger
  • Free open-source alternatives undercut it
  • Reddit debates whether it's even worth paying for

Sources & method

Analyzed 9/27/2026 - 10 sources - No known vulnerabilities found in the sources reviewed.

official x3review x6security x1

Key stats

  • Value for money: 3/5

    Rating

  • From $3/mo

    Starting price

  • 10

    Sources

  • Analyzed

  • Value for money: 3/5. Cheap entry price, but public pricing is sparse and dated
  • Ease of use: 4/5. G2 users consistently praise it
  • Feature depth: 4/5. Full workflow plus AI assistant and monitoring
  • Support quality. No support evidence found
  • Security posture: 4/5. Published security statement and GDPR compliance
  • $3/mo Starting price 360Quadrants listing, 2022
  • 174 G2 reviews reviews on G2
  • 2 Pricing plans per G2
  • 10 users Group plan cap max per group, official pricing

Pricing

Individual

From $3/mo

  • Discover, organize, read, annotate, cite

Group

Not publicly listed

  • Up to 10 users per group

Security

No known vulnerabilities found in the sources reviewed.

Companies that use it

  • Moderna⁶
  • Boehringer Ingelheim
  • Medscape
  • Roivant
Full analysis

Based on 20+ public sources; pricing partly dated (2022 listing), and several review snippets were truncated.

Legit, enterprise-tested literature manager for research-heavy orgs; overkill if you just save a few PDFs.

Methodology

Based on 20+ public sources; pricing partly dated (2022 listing), and several review snippets were truncated.

Sources

  1. review
  2. review
  3. review
  4. ReadCube Pricingabout.readcube.com
    official
  5. official
  6. Moderna Case Studyabout.readcube.com
    official
  7. ReadCube Security Statementabout.readcube.com
    security
  8. review
  9. review
  10. review

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.